Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Groningen, The Netherlands.
Innovation & Technical Solutions, DFE Pharma, Goch, Germany.
Expert Opin Drug Deliv. 2024 Jul;21(7):1069-1079. doi: 10.1080/17425247.2024.2384698. Epub 2024 Aug 12.
The pharmaceutical industry is gradually changing batch-wise manufacturing processes to continuous manufacturing processes, due to the advantages it has to offer. The final product quality and process efficiency of continuous manufacturing processes is among others impacted by the properties of the raw materials. Existing knowledge on the role of raw material properties in batch processing is however not directly transferable to continuous processes, due to the inherent differences between batch and continuous processes.
A review is performed to evaluate the role of excipient properties for different unit operations used in continuous manufacturing processes. Unit operations that will be discussed include feeding, blending, granulation, final blending, and compression.
Although the potency of continuous manufacturing is widely recognized, full utilization still requires a number of challenges to be addressed effectively. An expert opinion will be provided that discusses those challenges and potential solutions to overcome those challenges. The provided overview can serve as a framework for the pharmaceutical industry to push ahead process optimization and formulation development for continuous manufacturing processes.
由于连续制造工艺具有诸多优势,制药行业正逐渐将批处理制造工艺转变为连续制造工艺。连续制造工艺的最终产品质量和工艺效率受到原材料性能的影响。然而,由于批处理和连续处理之间存在固有差异,现有的关于原材料性能在批处理中的作用的知识不能直接应用于连续工艺。
本文通过评估辅料性能在连续制造工艺中使用的不同单元操作中的作用,进行了综述。将讨论的单元操作包括进料、混合、制粒、最终混合和压缩。
尽管连续制造的功效已得到广泛认可,但要充分利用它仍需要有效解决许多挑战。本文提供了一个专家意见,讨论了这些挑战以及克服这些挑战的潜在解决方案。所提供的概述可以为制药行业提供一个框架,以推动连续制造工艺的工艺优化和配方开发。